Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 319

1.

CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers.

Kono K, Kawaida H, Takahashi A, Sugai H, Mimura K, Miyagawa N, Omata H, Fujii H.

Cancer Immunol Immunother. 2006 Sep;55(9):1064-71. Epub 2005 Nov 23.

PMID:
16328385
2.

Distribution of CD4+CD25high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer.

Kawaida H, Kono K, Takahashi A, Sugai H, Mimura K, Miyagawa N, Omata H, Ooi A, Fujii H.

J Surg Res. 2005 Mar;124(1):151-7.

PMID:
15734494
3.

Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers.

Ichihara F, Kono K, Takahashi A, Kawaida H, Sugai H, Fujii H.

Clin Cancer Res. 2003 Oct 1;9(12):4404-8.

4.

CD4 CD25high regulatory T cells are not impaired in patients with primary Sjögren's syndrome.

Gottenberg JE, Lavie F, Abbed K, Gasnault J, Le Nevot E, Delfraissy JF, Taoufik Y, Mariette X.

J Autoimmun. 2005 May;24(3):235-42.

PMID:
15848046
5.

CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.

Shen LS, Wang J, Shen DF, Yuan XL, Dong P, Li MX, Xue J, Zhang FM, Ge HL, Xu D.

Clin Immunol. 2009 Apr;131(1):109-18. doi: 10.1016/j.clim.2008.11.010. Epub 2009 Jan 18.

PMID:
19153062
6.

Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.

Chaput N, Louafi S, Bardier A, Charlotte F, Vaillant JC, Ménégaux F, Rosenzwajg M, Lemoine F, Klatzmann D, Taieb J.

Gut. 2009 Apr;58(4):520-9. doi: 10.1136/gut.2008.158824. Epub 2008 Nov 20.

PMID:
19022917
7.

Numbers of Foxp3-expressing CD4+CD25high T cells do not correlate with the establishment of long-term tolerance after allogeneic stem cell transplantation.

Meignin V, Peffault de Latour R, Zuber J, Régnault A, Mounier N, Lemaître F, Dastot H, Itzykson R, Devergie A, Cumano A, Gluckman E, Janin A, Bandeira A, Socié G.

Exp Hematol. 2005 Aug;33(8):894-900.

PMID:
16038781
8.

Relationship of CD4+CD25+ regulatory T cells to immune status in HIV-infected patients.

Tsunemi S, Iwasaki T, Imado T, Higasa S, Kakishita E, Shirasaka T, Sano H.

AIDS. 2005 Jun 10;19(9):879-86.

PMID:
15905668
9.

CD4+CD25high regulatory cells in peripheral blood of cancer patients.

Liu L, Wu G, Yao JX, Ding Q, Huang SA.

Neuro Endocrinol Lett. 2008 Apr;29(2):240-5.

PMID:
18404145
10.

CD4+CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer.

Okita R, Saeki T, Takashima S, Yamaguchi Y, Toge T.

Oncol Rep. 2005 Nov;14(5):1269-73.

PMID:
16211295
11.

Regulatory T-cells are possible effect prediction markers of immunotherapy for cancer patients.

Wada J, Yamasaki A, Nagai S, Yanai K, Fuchino K, Kameda C, Tanaka H, Koga K, Nakashima H, Nakamura M, Tanaka M, Katano M, Morisaki T.

Anticancer Res. 2008 Jul-Aug;28(4C):2401-8.

12.

Potential role of CD4+CD25HIGH regulatory T cells in morbidity in Chagas disease.

Araujo FF, Gomes JA, Rocha MO, Williams-Blangero S, Pinheiro VM, Morato MJ, Correa-Oliveira R.

Front Biosci. 2007 May 1;12:2797-806.

PMID:
17485260
13.

CD4+CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patients.

Miller AM, Lundberg K, Ozenci V, Banham AH, Hellström M, Egevad L, Pisa P.

J Immunol. 2006 Nov 15;177(10):7398-405.

14.

[Detection of intracellular and extracellular cytokines of CD4+CD25+ regulatory T cells in gastric cancer patients].

Wang LY, Zeng Y, Pan ZZ, Zhu ZH.

Ai Zheng. 2007 Mar;26(3):270-3. Chinese.

PMID:
17355789
15.

Mucosal FOXP3-expressing CD4+ CD25high regulatory T cells in Helicobacter pylori-infected patients.

Lundgren A, Strömberg E, Sjöling A, Lindholm C, Enarsson K, Edebo A, Johnsson E, Suri-Payer E, Larsson P, Rudin A, Svennerholm AM, Lundin BS.

Infect Immun. 2005 Jan;73(1):523-31.

16.

CD4+CD25high regulatory cells in peripheral blood of NSCLC patients.

Liu L, Yao J, Ding Q, Huang S.

J Huazhong Univ Sci Technolog Med Sci. 2006;26(5):548-51.

PMID:
17219964
17.

CD4 + CD25high regulatory T cell numbers and FOXP3 mRNA expression in patients with advanced esophageal cancer before and after chemotherapy.

Xu T, Duan Q, Wang G, Hu B.

Cell Biochem Biophys. 2011 Nov;61(2):389-92. doi: 10.1007/s12013-011-9197-1.

PMID:
21607687
18.

Homeostasis of peripheral FoxP3(+) CD4 (+) regulatory T cells in patients with early and late stage breast cancer.

Rech AJ, Mick R, Kaplan DE, Chang KM, Domchek SM, Vonderheide RH.

Cancer Immunol Immunother. 2010 Apr;59(4):599-607. doi: 10.1007/s00262-009-0780-x. Epub 2009 Oct 24.

PMID:
19855964
19.

Dysfunction of CD4+CD25high T regulatory cells in patients with recurrent aphthous stomatitis.

Lewkowicz N, Lewkowicz P, Dzitko K, Kur B, Tarkowski M, Kurnatowska A, Tchórzewski H.

J Oral Pathol Med. 2008 Sep;37(8):454-61. doi: 10.1111/j.1600-0714.2008.00661.x. Epub 2008 Mar 3.

PMID:
18318707
20.

Increased survival from stage IV melanoma associated with fewer regulatory T Cells.

Baumgartner JM, Gonzalez R, Lewis KD, Robinson WA, Richter DA, Palmer BE, Wilson CC, McCarter MD.

J Surg Res. 2009 Jun 1;154(1):13-20. doi: 10.1016/j.jss.2008.04.043. Epub 2008 Jun 2.

PMID:
19062042

Supplemental Content

Support Center